Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal tract lumen osmolality is the measure of solute concentration (osmoles per kilogram of solvent) in the liquid contents of the GI tract. It plays a critical role in the movement of water and solutes across the gut wall, influencing both digestion and fluid homeostasis. Changes in GI lumen osmolality can be sensed and signaled neuro-hormonally to the brain, particularly influencing thirst and satiety mechanisms. Clinically, manipulation of GI osmolality underlies the therapeutic action of osmotic laxatives and can affect the absorption of orally administered drugs. Pathologically, abnormal GI osmolality contributes to conditions such as osmotic diarrhea and electrolyte disturbances.
Induction of osmosis: Compounds increase GI lumen osmolality, pulling water into the lumen and promoting laxation (osmotic laxatives). Modulation of GI fluid volume may alter drug absorption kinetics (certain drugs, e.g., atenolol, may have decreased absorption in hyperosmotic environments).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal tract lumen osmolality.